University of Ioannina
Μελέτη της αντικαρκινικής δράσης και του μηχανισμού της κουρκουμίνης στο γλοιοβλάστωμα
Abstract
dc:descriptionGlioblastoma is one of the deadliest tumors of the central nervous system, with an average patient survival of approximately 15 months after diagnosis. Current treatment options based on surgical resection followed by a combination of chemotherapy and radiotherapy do not significantly increase patient survival. For this reason, the need to find new safe, and effective anti-glioma agents is considered essential. In this context, many modern research efforts have turned to the study of plant extracts or molecules isolated from plants. Curcumin is a polyphenol isolated from the plant Curcuma longa and has shown significant anticancer properties in various types of neoplasms. In the present study, the antiglioma activity of curcumin and its underlying mechanism were investigated in 2 human glioblastoma cell lines in vitro, either as monotherapy or in combination with current therapeutic approaches, such as radiotherapy and chemotherapy with the approved alkylating agent temozolomide. For this purpose, the effect of curcumin on cell proliferation was evaluated by methyl-triazolyl-tetrazolium (MTT) cytotoxicity assay, Trypan Blue Exclusion Assay and Crystal Violet staining. In addition, its effect on cell cycle progression was investigated by flow cytometry, and the effect on the migratory ability of the cells by the scratch wound healing assay. Testing for synergism of curcumin and radiotherapy or curcumin and temozolomide was assessed by the Trypan Blue Exclusion Assay and CompuSyn software (based on the measurement of the Combination Index). The effect of curcumin on the expression of the pro-apoptotic protein Bcl2, as well as pro-caspase 3 was evaluated by Western blot immunoprinting. Finally, a toxicity test of curcumin was performed in a zebrafish model. Based on the results of the present thesis, curcumin significantly inhibited cell proliferation in both cell lines and induced dose-dependent cell cycle arrest in the G2/M phase. Curcumin also inhibited cell migration in both lines, reduced the levels of Bcl2 protein, as well as pro-caspase 3, indicating that its antiproliferative action is related to the induction of apoptosis. In addition, pretreatment of cells with increasing concentrations of curcumin before exposure to radiation reduced cell viability to a greater extent than monotherapy with curcumin or radiation (synergistic effect). Co-administration of curcumin and temozolomide also showed a synergistic effect in most tested combinations. Finally, in an in vivo zebrafish model, the mean lethal concentration (LC50) of curcumin was lower compared to its IC50 values against glioblastoma cells, suggesting that curcumin shows more selectivity towards cancer cells. Our results demonstrate that curcumin is a promising anti-glioma agent that can sensitize glioblastoma cells to both radiotherapy and chemotherapy.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zoi, Vasiliki
- Ζώη, Βασιλική
Subjects
dc:subject × 18- Κουρκουμίνη
- Γλοιοβλάστωμα
- Χημειοακτινοθεραπεία
- Τεμοζολομίδη
- Απόπτωση
- Curcumin
- Glioblastoma multiforme
- Chemio-radiotherapy
- Temozolomide
- Apoptosis
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ανακάλυψη και Ανάπτυξη φαρμάκων
- Νευροεπιστήμες
- Basic Medicine
- Medical and Health Sciences
- Drug Discovery
- Neurosciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54073